This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Boehringer Ingelheim International Gmbh, Mitsubishi Tanabe Pharma Corporation. Active years: 2014-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sakai, JP (2014)
- Osaka, JP (2014 - 2020)
Company Filing History:


Years Active: 2014-2020
Title: Kazutoshi Yokoyama: Innovator in Pharmaceutical Science
Introduction
Kazutoshi Yokoyama is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical science, holding a total of four patents. His work focuses on developing innovative pharmaceutical compositions and treatments.
Latest Patents
Yokoyama's latest patents include a pharmaceutical composition and dosage form comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide. This invention relates to pharmaceutical compositions that utilize this compound as an active ingredient, particularly in the form of hydrochloride for therapeutic treatments. Another notable patent is for a novel antiplatelet agent, which includes a compound represented by a specific formula. This invention aims to provide effective treatment options for patients requiring antiplatelet therapy.
Career Highlights
Throughout his career, Kazutoshi Yokoyama has worked with leading companies in the pharmaceutical industry, including Mitsubishi Tanabe Pharma Corporation and Boehringer Ingelheim International GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and therapeutic applications.
Collaborations
Yokoyama has collaborated with notable colleagues such as Hiroshi Sato and Kazushi Sato. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Kazutoshi Yokoyama is a distinguished inventor whose work in pharmaceutical science has led to significant advancements in drug development. His innovative patents and collaborations highlight his commitment to improving healthcare through effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile